CK
Colleen Kusy Baird Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
14
Avg Return
Past Year
Past Year
41%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
72.7%
Neutral
27.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $12 |
6%
upside
| 2 | +164% |
0
%
| 6 Mar ‘26 3 months ago |
|
|
|
Neutral
Maintained
| $867 |
1%
downside
| 2 | – |
–
| 27 Feb ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $158 |
28%
upside
| 2 | +17% |
0
%
| 18 Nov ‘25 7 months ago |
|
|
|
Neutral
Maintained
| $34 |
4%
upside
| 1 | – |
–
| 11 Nov ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $52 |
27%
upside
| 3 | +2.1% |
0
%
| 31 Oct ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $24 |
176%
upside
| 1 | -22% |
0
%
| 3 Oct ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $52 |
21%
upside
| 1 | +26% |
0
%
| 16 Jun ‘25 1 year ago |
|